Records containing: Neuroendocrine Tumor Grade 1
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-11-04A Phase 1, First-in-human Clinical Trial of [212Pb] VMT-alpha-NET Using a Forward Dosimetric Planning Technique to Treat Refractory or Relapsed Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2025-07-22177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry
-
CLINICAL_TRIALS study record update · 2025-07-14A Phase 0 First-in-human Clinical Trial of [203Pb]VMT-α-NET SPECT/CT for Somatostatin Receptor Imaging of Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2025-05-25Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Low Grade Pancreatic Neuroendocrine Tumors of Less Than 2cm in Size
-
CLINICAL_TRIALS study record update · 2025-04-03Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN. REBORN Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-03-03Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial
-
CLINICAL_TRIALS study record update · 2024-06-25Randomized Phase II Trial of Everolimus 5 mg vs 10 mg/Daily for Patients With Advanced Neuroendocrine Tumors